Investor and analyst meet set for 5 November to discuss FY27 results

Board & Shareholder Meetings View source PDF Explain this filing

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹353.00

prior close

₹345.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 170sector+0.6%+0.4% vs sector

On the reaction day the stock moved 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+1.4

15m

+1.1

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0pendingpending+0.6+0.4

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Themis Biosyn will hold a physical investor and analyst meet on 5 November 2026 from 4:00 PM onwards at Salon Pompadour, Sofitel, Bandra Kurla Complex, Mumbai, to discuss its second-quarter and first-half FY27 financial results. The schedule was issued on 27 October 2026 and includes no financial figures.

Likely market impact

No financial results were disclosed. The meeting may help investors understand FY27 performance, but the filing itself does not indicate any change in the business.